VL
Visia Lab provides integrated hardware and software platforms for in‑vitro diagnostic laboratories, supporting cytology, digital pathology, immunoassays, immunofluorescence, big‑data analytics, and genetic testing. It offers turnkey product development, third‑party design services, and licenses proprietary diagnostic technologies to medical device manufacturers and diagnostic service providers.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Visia Lab designs, develops, and manufactures integrated hardware and software platforms for in‑vitro diagnostic (IVD) laboratories, covering applications such as cytology, digital pathology, immunoassays, immunofluorescence, big‑data analytics, and genetic testing. The company serves global medical device manufacturers and diagnostic service providers on a business‑to‑business basis, delivering turnkey product development and third‑party design services. Revenue is generated through project‑based contracts, product sales, and licensing of proprietary diagnostic technologies.